Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,002 public trials 1,214 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma

NCT00025649

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • St. Anna Children's Hospital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen, Denmark
  • Centre Hospitalier Regional de Purpan Toulouse, France
View Trial Details
Completed

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

NCT00276679

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Centre Hospitalier Regional de Purpan Toulouse, France
  • Our Lady's Hospital for Sick Children Dublin, Ireland
  • Birmingham Children's Hospital Birmingham, England, United Kingdom
  • Institute of Child Health at University of Bristol Bristol, England, United Kingdom
View all 22 locations
View Trial Details
Completed

Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.

NCT00025597

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • St. Anna Children's Hospital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen, Denmark
  • Centre Hospitalier Regional de Purpan Toulouse, France
View Trial Details
Completed

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

NCT00395070

Conditions
Melanoma, Metastatic Melanoma, Neoplasm Metastasis, +14 more
Locations
  • Location #40 Tucson, Arizona, United States
  • Location #9 Little Rock, Arkansas, United States
  • Location #1 Bakersfield, California, United States
  • Location #24 San Diego, California, United States
View all 88 locations
View Trial Details
Completed

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

NCT00498836

Conditions
Malignant Melanoma, Melanoma, Neoplasm Metastasis, +14 more
Locations
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
  • Cancer Therapy and Research Center, Institute for Drug Development San Antonio, Texas, United States
  • The Norwegian Radium Hospital Oslo, Norway
  • Lund University Hospital Lund, Sweden
View Trial Details
Completed

Combination Chemotherapy in Treating Children With Progressive Brain Tumors

NCT00002944

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +22 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 204 locations
View Trial Details

Related conditions